Agreement of Mammographic Measures of Volumetric Breast Density to MRI

被引:31
作者
Wang, Jeff [1 ]
Azziz, Ania [1 ]
Fan, Bo [1 ]
Malkov, Serghei [1 ]
Klifa, Catherine [2 ]
Newitt, David [1 ]
Yitta, Silaja [1 ]
Hylton, Nola [1 ]
Kerlikowske, Karla [3 ,4 ]
Shepherd, John A. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[2] Synarc Inc, Newark, CA USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Epidemiol Biostat, San Francisco, CA 94143 USA
来源
PLOS ONE | 2013年 / 8卷 / 12期
关键词
CANCER RISK; SCREENING MAMMOGRAPHY; TISSUE COMPOSITION; BODY-COMPOSITION; TAMOXIFEN; WOMEN; MODEL; REDUCTION; PATTERNS; INDEX;
D O I
10.1371/journal.pone.0081653
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Clinical scores of mammographic breast density are highly subjective. Automated technologies for mammography exist to quantify breast density objectively, but the technique that most accurately measures the quantity of breast fibroglandular tissue is not known. Purpose: To compare the agreement of three automated mammographic techniques for measuring volumetric breast density with a quantitative volumetric MRI-based technique in a screening population. Materials and Methods: Women were selected from the UCSF Medical Center screening population that had received both a screening MRI and digital mammogram within one year of each other, had Breast Imaging Reporting and Data System (BI-RADS) assessments of normal or benign finding, and no history of breast cancer or surgery. Agreement was assessed of three mammographic techniques (Single-energy X-ray Absorptiometry [SXA], Quantra, and Volpara) with MRI for percent fibroglandular tissue volume, absolute fibroglandular tissue volume, and total breast volume. Results: Among 99 women, the automated mammographic density techniques were correlated with MRI measures with R-2 values ranging from 0.40 (log fibroglandular volume) to 0.91 (total breast volume). Substantial agreement measured by kappa statistic was found between all percent fibroglandular tissue measures (0.72 to 0.63), but only moderate agreement for log fibroglandular volumes. The kappa statistics for all percent density measures were highest in the comparisons of the SXA and MRI results. The largest error source between MRI and the mammography techniques was found to be differences in measures of total breast volume. Conclusion: Automated volumetric fibroglandular tissue measures from screening digital mammograms were in substantial agreement with MRI and if associated with breast cancer could be used in clinical practice to enhance risk assessment and prevention.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model
    Brentnall, Adam R.
    Cohn, Wendy F.
    Knaus, William A.
    Yaffe, Martin J.
    Cuzick, Jack
    Harvey, Jennifer A.
    JOURNAL OF BREAST IMAGING, 2019, 1 (02) : 99 - 106
  • [22] Determinants of Percentage and Area Measures of Mammographic Density
    Stone, Jennifer
    Warren, Ruth M. L.
    Pinney, Elizabeth
    Warwick, Jane
    Cuzick, Jack
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (12) : 1571 - 1578
  • [23] Mammographic density and breast cancer screening
    Bell, R. J.
    CLIMACTERIC, 2020, 23 (05) : 460 - 465
  • [24] Medication use and mammographic breast density
    Han, Yunan
    Lee, Chee Teik
    Xu, Shuai
    Mi, Xiaoyue
    Phillip, Courtnie R.
    Salazar, Ana S.
    Rakhmankulova, Malika
    Toriola, Adetunji T.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 585 - 592
  • [25] Familial Aspects of Mammographic Density Measures Associated with Breast Cancer Risk
    Nguyen, Tuong L.
    Li, Shuai
    Dowty, James G.
    Dite, Gillian S.
    Ye, Zhoufeng
    Nguyen-Dumont, Tu
    Trinh, Ho N.
    Evans, Christopher F.
    Tan, Maxine
    Sung, Joohon
    Jenkins, Mark A.
    Giles, Graham G.
    Southey, Melissa C.
    Hopper, John L.
    CANCERS, 2022, 14 (06)
  • [26] Association of mammographic density measures and breast cancer "intrinsic" molecular subtypes
    Kleinstern, Geffen
    Scott, Christopher G.
    Tamimi, Rulla M.
    Jensen, Matthew R.
    Pankratz, V. Shane
    Bertrand, Kimberly A.
    Norman, Aaron D.
    Visscher, Daniel W.
    Couch, Fergus J.
    Brandt, Kathleen
    Shepherd, John
    Wu, Fang-Fang
    Chen, Yunn-Yi
    Cummings, Steven R.
    Winham, Stacey
    Kerlikowske, Karla
    Vachon, Celine M.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 215 - 224
  • [27] Racial Differences in Quantitative Measures of Area and Volumetric Breast Density
    McCarthy, Anne Marie
    Keller, Brad M.
    Pantalone, Lauren M.
    Hsieh, Meng-Kang
    Synnestvedt, Marie
    Conant, Emily F.
    Armstrong, Katrina
    Kontos, Despina
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (10):
  • [28] The effects of raloxifene on mammographic breast density: a review of clinical trials
    Pearman, Leny
    Kagan, Risa
    Arsenault, Jody
    Muram, David
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (03): : 654 - 659
  • [29] A Novel Automated Mammographic Density Measure and Breast Cancer Risk
    Heine, John J.
    Scott, Christopher G.
    Sellers, Thomas A.
    Brandt, Kathleen R.
    Serie, Daniel J.
    Wu, Fang-Fang
    Morton, Marilyn J.
    Schueler, Beth A.
    Couch, Fergus J.
    Olson, Janet E.
    Pankratz, V. Shane
    Vachon, Celine M.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (13) : 1028 - 1037
  • [30] Automated Measurement of Volumetric Mammographic Density: A Tool for Widespread Breast Cancer Risk Assessment
    Brand, Judith S.
    Czene, Kamila
    Shepherd, John A.
    Leifland, Karin
    Heddson, Boel
    Sundbom, Ann
    Eriksson, Mikael
    Li, Jingmei
    Humphreys, Keith
    Hall, Per
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (09) : 1764 - 1772